Stock Scorer

Alamar Biosciences, Inc. (ALMR) · Insider trading

What Alamar Biosciences's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$8.00M
1 insider, 2 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
+$8.00M
bought less sold
Latest filing
2026-09-16
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-07 2026-01 2026-04: $8.00M bought 2026-07
Bought Sold Largest month: $8.00M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Naclerio Nicholas10% owner $8.00M – 2 2026-04-20 –

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-04-20 Naclerio Nicholas10% ownerwith Illumina Innovation Fund II, L.P., Illumina Innovation Fund II GP, L.L.C., Illumina Innovation Fund III, L.P., Illumina Innovation Fund III GP, L.L.C. Buyindirect 235,294 17.00 $4.00M 507,076 Form 4
2026-04-20 Naclerio NicholasDirector Buyindirect 235,294 17.00 $4.00M 507,076 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

20 × other17 × conversion7 × grant or award
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-14 Brottem John L.General Counsel Grant or award A +29,000 – 29,000 Form 4
2026-09-01 Ragusa Robert PDirector Grant or award A +5,686 – 5,686 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Conversion C +185,163 – 185,163 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Conversion C +6,881,410 – 6,881,410 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Conversion C +1,605,645 – 1,605,645 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Conversion C +1,922,329 – 1,922,329 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Other J −185,163 – 0 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Other J −6,881,410 – 0 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Other J −1,605,645 – 0 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Other J −1,922,329 – 0 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Other J +185,163 – 185,163 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Other J +6,881,410 – 6,881,410 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Other J +1,605,645 – 1,605,645 Form 4
2026-04-20 Qiming Venture Partners VI, L.P.10% owner Other J +1,922,329 – 1,922,329 Form 4
2026-04-20 Naclerio Nicholas10% owner Conversion C +4,588,364 – 4,588,364 Form 4
2026-04-20 Naclerio Nicholas10% owner Conversion C +922,152 – 5,510,516 Form 4
2026-04-20 Naclerio Nicholas10% owner Other J −5,510,516 – 0 Form 4
2026-04-20 Naclerio Nicholas10% owner Other J +5,510,516 – 5,510,516 Form 4
2026-04-20 Naclerio Nicholas10% owner Conversion C +346,020 – 5,856,536 Form 4
2026-04-20 Naclerio Nicholas10% owner Conversion C +271,782 – 271,782 Form 4
2026-04-20 Naclerio NicholasDirector Conversion C +4,588,364 – 4,588,364 Form 4
2026-04-20 Naclerio NicholasDirector Conversion C +922,152 – 5,510,516 Form 4
2026-04-20 Naclerio NicholasDirector Other J −5,510,516 – 0 Form 4
2026-04-20 Naclerio NicholasDirector Other J +5,510,516 – 5,510,516 Form 4
2026-04-20 Naclerio NicholasDirector Conversion C +346,020 – 5,856,536 Form 4
2026-04-20 Naclerio NicholasDirector Conversion C +271,782 – 271,782 Form 4
2026-04-20 Naclerio NicholasDirector Grant or award A +5,686 – 5,686 Form 4
2026-04-20 McAnear Justin J.Chief Financial Officer Grant or award A +37,220 – 37,220 Form 4
2026-04-20 White Timothy OgdenPresident Other J −454,583 – 0 Form 4
2026-04-20 White Timothy OgdenPresident Other J +454,583 – 454,583 Form 4
2026-04-20 White Timothy OgdenPresident Grant or award A +37,220 – 491,803 Form 4
2026-04-20 Luo YulingDirector, Chief Executive Officer Conversion C +1,386,746 – 1,499,797 Form 4
2026-04-20 Luo YulingDirector, Chief Executive Officer Conversion C +364,268 – 1,864,065 Form 4
2026-04-20 Luo YulingDirector, Chief Executive Officer Other J −1,864,065 – 0 Form 4
2026-04-20 Luo YulingDirector, Chief Executive Officer Other J +1,864,065 – 1,864,065 Form 4
2026-04-20 Luo YulingDirector, Chief Executive Officer Grant or award A +76,509 – 1,940,574 Form 4
2026-04-20 Luo YulingDirector, Chief Executive Officer Conversion C +1,224,152 – 1,224,152 Form 4
2026-04-20 Luo YulingDirector, Chief Executive Officer Other J −1,224,152 – 0 Form 4
2026-04-20 Luo YulingDirector, Chief Executive Officer Other J +1,224,152 – 1,224,152 Form 4
2026-04-20 Chen ShipingDirector, Chief Operating Officer Conversion C +320,511 – 650,032 Form 4
2026-04-20 Chen ShipingDirector, Chief Operating Officer Conversion C +72,853 – 722,885 Form 4
2026-04-20 Chen ShipingDirector, Chief Operating Officer Other J −722,885 – 0 Form 4
2026-04-20 Chen ShipingDirector, Chief Operating Officer Other J +722,885 – 722,885 Form 4
2026-04-20 Chen ShipingDirector, Chief Operating Officer Grant or award A +37,220 – 760,105 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Alamar Biosciences's scores and multiples ›